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Background
Left ventricular (LV) systolic dysfunction is associated
with a 2 to 3 fold increase in the risk of stroke. Although
the pathophysiology underlying this association is com-
plex, the presence of LV thrombus (LVT) is thought to
contribute at least in part to this increased risk. Using
trans-thoracic echocardiography (TTE), the prevalence of
LVT in chronic heart failure is reported to be 20–40%.
More recently contrast enhanced cardiac magnetic reso-
nance imaging (CE-CMR) has emerged as an important
non-invasive tool for the assessment of heart failure and
has the capability to diagnose LVT with greater ease than
TTE.
Aims
(1) To examine the prevalence of LVT as detected by CE-
CMR in a consecutive series of patients with chronic LV
dysfunction referred for coronary artery bypass surgery
(CABG). (2) To compare the rates of detection of LVT
between CMR and TTE/ventriculography in this popula-
tion of patients.
Methods
44 patients with impaired ventricular function (EF meas-
ured by CMR < 50%) scheduled for isolated elective CABG
were recruited, and underwent conventional LV assess-
ment (TTE and LV angiography) as part of the clinical pre-
operative assessment, and CMR as part of a research pro-
tocol. All CMR examinations were performed on a 1.5
Tesla Siemens Sonata scanner, CE-CMR images were
acquired in three long axis planes using steady state free
precession imaging (flip angle 60° TE/TR 1.6/700 TI 450
ms or ultra fast gradient echo imaging (flip angle 25° TE/
TR 4.3/750 TI 450 ms) following a bolus injection of
Gadodiamide (Omniscan 0.1.mmol/kg body weight).
The CMR images were analysed for the presence of LVT by
two blinded observers working in consensus. LVT was
defined as a filling defect characteristically present at the
apex, or associated with an area of wall motion abnormal-
ity that was seen in 2 image planes. Artefact was character-
ised by a filling defect present in only the read out
direction (chemical shift), was seen within the wall of the
myocardium (no-reflow phenomenon) or was visualised
in only one plane.
Results
The overall mean age was 66 ± 8 years and 93% were
male. Eight out of 44 patients (18%) had LVT identified
by CE-CMR. Patients with LVT tended to have a lower
ejection fraction and increased LV volumes, however none
of these comparisons were statistically significant, Table 1.
Patients with LVT were significantly younger (61 ± 10
years) than patients in whom thrombus was not identi-
fied (67 ± 7 years) p = 0.03, Table 1. Logistic regression
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LVT, with younger age indicating a higher risk, Table 2.
Conventional imaging identified the presence of LVT in
only 3 patients, 2 by LV angiography and 1 by TTE. Two
patients with LVT identified by CE-CMR had sustained a
stroke within 6 months of their CMR scan, Patients A and
C, Figure 1.
Conclusion
LVT is difficult to diagnose by conventional imaging tech-
niques and CE-CMR may have a role in the pre-operative
assessment of this group, both for viability assessment
and LVT detection. LVT was more likely to be present in
younger patients presenting with heart failure, and factors
that are associated with premature ischemic heart disease
may also influence the prevalence of LVT.
Table 1: Patient demographics of patients with and without 
LVT.
LVT + LVT -
Age (years) 61 ± 10 67 ± 7*
Male 100 (8/8) 92 (33/36)
Smoking 25 (2/8) 8 (6/36)
Diabetes 38 (3/8) 33 (12/36)
Q waves 50 (4/8) 56 (20/36)
LVEF (%) 37 ± 14 39 ± 11
LVEDVI (ml.m-2) 136 ± 40 114 ± 31
LVESVI (ml.m-2) 89 ± 41 72 ± 31
DHE (grams) 31 ± 5 25 ± 13
Warfarin 25 (2/8) 6 (2/36)
ACE inhibitor 88 (7/8) 94 (34/36)
EURO Score 7.9 ± 4.6 10.3 ± 9
Demographics expressed as percentage (absolute values) or mean ± 
SD for continuous variables. LVEF, Left ventricular ejection fraction; 
LVEDVI, left ventricular end-diastolic volume index; LVESVI, left 
ventricular end-systolic volume index; DHE, delayed 
hyperenhancement; ACE, angiotensin converting enzyme. *p = 0.03.
Table 2: Forward stepwise logistic regression analysis for the risk 
factors associated with the presence of LV thrombus.
95% CI for exp b
B (SE) Lower exp B Upper
Included
Constant 5.8 (3.5)* 2510
Age -0.12 (0.06)* 0.760 0.892 0.978
*p < 0.05, Nagelkerke R2 = 0.169, Cox & Snell R2 = 0.104, -2 Log 
likelihood = 36.917.Page 2 of 3
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Patient A had thrombus using ultra fast gradient echo sequence early after IV Gd-DTPA administration, LVT was present at the apexFigure 1
Patient A had thrombus using ultra fast gradient echo sequence early after IV Gd-DTPA administration, LVT was present at the 
apex. This patient sustained a stroke prior to CABG. Patient B had a small apical aneurysm, thrombus was visualised in only the 
LVOT plane on the steady state free precession imaging. As image quality on the early post gad image was impaired by respira-
tory artefact, the thrombus was confirmed using the delayed hyperenhancement sequence (ultrafast gradient echo TE/TR 4.3/
750 TI 270–350). Patient B had LVT diagnosed on conventional imaging (LV angiography). Patient C had thrombus detected by 
post contrast image steady state free precession imaging, which demonstrated LVT at the apex, this patient had sustained a 
stroke 4 months prior to CABG.
